![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
RETRACTION article
Front. Immunol. , 03 July 2024
Sec. B Cell Biology
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1455372
This article is a retraction of:
RETRACTED: Tlr5 deficiency exacerbates lupus-like disease in the MRL/lpr mouse model
A Retraction of the Original Research Article
Tlr5 deficiency exacerbates lupus-like disease in the MRL/lpr mouse model
By Alajoleen RM, Oakland DN, Estaleen R, Shakeri A, Lu R, Appiah M, Sun S, Neumann J, Kawauchi S, Cecere TE, McMillan RP, Reilly CM and Luo XM (2024). Front. Immunol. 15:1359534. doi: 10.3389/fimmu.2024.1359534
Following publication, concerns were raised regarding the integrity of the data in the published figures and the validity of the data presented in the article.
The authors assisted in the investigation of this manuscript, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, the editors and the authors no longer have confidence in the findings presented in the article and concur with the retraction.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors regret any inconvenience this may have caused to the reviewers, editors, and readers of Frontiers in Immunology.
Citation: Frontiers Editorial Office (2024) Retraction: Tlr5 deficiency exacerbates lupus-like disease in the MRL/lpr mouse model. Front. Immunol. 15:1455372. doi: 10.3389/fimmu.2024.1455372
Received: 26 June 2024; Accepted: 26 June 2024;
Published: 03 July 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.